Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Plasencia, N. Maíz, S. Bonino, C. Kaihura, K. Nicolaides (2007)
Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre‐eclampsiaUltrasound in Obstetrics and Gynecology, 30
L. Milio, J. Hu, G. Douglas (1994)
Binding of insulin-like growth factor I to human trophoblast cells during differentiation in vitro.Placenta, 15 6
Kaaja (1995)
Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant womenObstet Gynecol, 85
Khong (1986)
Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infantsBJOG, 93
R. Kazer (2003)
A hypothesis for altered activity of insulin‐like growth factor I in women with pre‐eclampsiaInternational Journal of Gynecology & Obstetrics, 80
(2006)
Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction
K. Altınkaynak, H. Aksoy, E. Bakan, Y. Kumtepe (2003)
Serum IGF-I and IGFBP-3 in healthy pregnancies and patients with preeclampsia.Clinical biochemistry, 36 3
Christina Yu, Gordon Smith, A. Papageorghiou, A. Cacho, K. Nicolaides (2005)
An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women.American journal of obstetrics and gynecology, 193 2
R. Kaaja, M. Tikkanen, L. Viinikka, O. Ylikorkala (1995)
Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant womenInternational Journal of Gynecology & Obstetrics, 51
J. Meekins, R. Pijnenborg, M. Hanssens, I. Mcfadyen, A. Asshe (1994)
A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre‐eclamptic pregnanciesBJOG: An International Journal of Obstetrics & Gynaecology, 101
J. Bartha, Raquel Romero‐Carmona, Rafael Torrejón-Cardoso, R. Comino‐Delgado (2002)
Insulin, insulin-like growth factor-1, and insulin resistance in women with pregnancy-induced hypertension.American journal of obstetrics and gynecology, 187 3
Y. Koçyigit, G. Bayhan, A. Atamer, Y. Atamer (2004)
Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistanceGynecological Endocrinology, 18
DJ Fowler, K Nicolaides, John Miell (2000)
Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract.Human reproduction update, 6 5
Marshall Lindheimer, A. Katz (1981)
Pathophysiology of preeclampsia.Annual review of medicine, 32
R. Monzavi, P. Cohen (2002)
IGFs and IGFBPs: role in health and disease.Best practice & research. Clinical endocrinology & metabolism, 16 3
A. Halhali, A. Tovar, N. Torres, H. Bourges, M. Garabédian, F. Larrea (2000)
Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments.The Journal of clinical endocrinology and metabolism, 85 5
K. Forbes, M. Westwood (2008)
The IGF Axis and Placental FunctionHormone Research in Paediatrics, 69
S. Smith, R. Francis, L. Guilbert, P. Baker (2002)
Growth factor rescue of cytokine mediated trophoblast apoptosis.Placenta, 23 4
V. Han, N. Bassett, J. Walton, J. Challis (1996)
The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface.The Journal of clinical endocrinology and metabolism, 81 7
K. Kagan, D. Wright, A. Baker, D. Sahota, K. Nicolaides (2008)
Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐AUltrasound in Obstetrics and Gynecology, 31
L. Vatten, R. Skjærven (2004)
Is pre‐eclampsia more than one disease?BJOG: An International Journal of Obstetrics & Gynaecology, 111
W. Grobman, R. Kazer (2001)
Serum Insulin, Insulin‐Like Growth Factor‐I, and Insulin‐Like Growth Factor Binding Protein‐1 in Women Who Develop PreeclampsiaObstetrics & Gynecology, 97
R. Snijders, P. Noble, N. Sebire, A. Souka, K. Nicolaides (1998)
UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestationThe Lancet, 352
A. Hübinette, P. Lichtenstein, K. Brismar, L. Vatten, G. Jacobsen, A. Ekbom, S. Cnattingius (2003)
Serum insulin‐like growth factors in normal pregnancy and in pregnancies complicated by preeclampsiaActa Obstetricia et Gynecologica Scandinavica, 82
Y. Ning, M. Williams, S. Vadachkoria, M. Muy-Rivera, I. Frederick, D. Luthy (2004)
Maternal plasma concentrations of insulinlike growth factor-1 and insulinlike growth factor-binding protein-1 in early pregnancy and subsequent risk of preeclampsia.Clinical biochemistry, 37 11
T. Khong, F. Wolf, W. Robertson, I. Brosens (1987)
Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants.British journal of obstetrics and gynaecology, 93 10
Friedman (1991)
Pathophysiology of preeclampsiaClin Perinatol, 18
A. Halhali, H. Bourges, A. Carrillo, M. Garabédian (1995)
Lower circulating insulin-like growth factor I and 1,25-dihydroxyvitamin D levels in preeclampsia.Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 47 4
H. Lacey, T. Haigh, M. Westwood, J. Aplin (2002)
Mesenchymally-derived Insulin-like growth factor 1 provides a paracrine stimulus for trophoblast migrationBMC Developmental Biology, 2
D. Clemmons, A. Moses, M. McKay, A. Sommer, D. Rosen, J. Ruckle (2000)
The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.The Journal of clinical endocrinology and metabolism, 85 4
B. Lorentzen, K. Birkeland, M. Endresen, T. Henriksen (1998)
Glucose intolerance in women with preeclampsiaActa Obstetricia et Gynecologica Scandinavica, 77
W. Lerberghe, A. Manuel, Z. Matthews, Wolfheim Cathy (2005)
The World Health Report 2005 - make every mother and child count
M. Ingec, H. Gursoy, L. Yildiz, Y. Kumtepe, S. Kadanali (2004)
Serum levels of insulin, IGF‐1, and IGFBP‐1 in pre‐eclampsia and eclampsiaInternational Journal of Gynecology & Obstetrics, 84
(2002)
Diagnosis and management of preeclampsia and eclampsiaInternational Journal of Gynecology & Obstetrics, 77
ACOG Committee (2002)
Diagnosis and management of preeclampsia and eclampsia. 2002. ACOG Committee on Practice Bulletins-ObstetricsObstet Gynecol, 99
M. Lewitt, Fergus Scott, Clarke Nm, T. Wu, M. Sinosich, R. Baxter (1998)
Regulation of insulin-like growth factor-binding protein-3 ternary complex formation in pregnancy.The Journal of endocrinology, 159 2
L. Poon, I. Staboulidou, N. Maíz, W. Plasencia, K. Nicolaides (2009)
Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeksUltrasound in Obstetrics and Gynecology, 34
H. Olausson, M. Lof, K. Brismar, M. Lewitt, E. Forsum, A. Sohlstrom (2007)
Longitudinal Study of the Maternal Insulin-Like Growth Factor System before, during and after Pregnancy in Relation to Fetal and Infant WeightHormone Research in Paediatrics, 69
R. Randhawa, P. Cohen (2005)
The role of the insulin-like growth factor system in prenatal growth.Molecular genetics and metabolism, 86 1-2
M. Sowers, T. Scholl, J. Grewal, X. Chen, M. Jannausch (2001)
IGF-I, osteocalcin, and bone change in pregnant normotensive and pre-eclamptic women.The Journal of clinical endocrinology and metabolism, 86 12
M. Brown, M. Lindheimer, M. Swiet, A. Assche, J. Moutquin (2001)
The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP).Hypertension in Pregnancy, 20
L. Giudice, Natalie Martina, Ruth Crystal, S. Tazuke, M. Druzin (1997)
Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia.American journal of obstetrics and gynecology, 176 4
Brown (2001)
The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)Hypertens Pregnancy, 20
Lorentzen (1998)
Glucose intolerance in women with pre-eclampsiaActa Obstet Gynecol, 77
U. Högberg (2005)
The World Health Report 2005: ``Make every mother and child count'' — including AfricansScandinavian Journal of Public Health, 33
R. D’Anna, G. Baviera, F. Corrado, D. Giordano, A. Vivo, G. Nicocia, A. Benedetto (2006)
Adiponectin and insulin resistance in early‐ and late‐onset pre‐eclampsiaBJOG: An International Journal of Obstetrics & Gynaecology, 113
J. Aplin, H. Lacey, T. Haigh, C. Jones, C. Chen, M. Westwood (2000)
Growth factor-extracellular matrix synergy in the control of trophoblast invasion.Biochemical Society transactions, 28 2
Objective To investigate the maternal serum concentration of insulin‐like growth factor‐I (IGF‐I) in the first trimester of pregnancies that subsequently develop preeclampsia (PE) and to examine the possible association with uterine artery pulsatility index (PI). Methods The maternal serum concentration of IGF‐I and uterine artery PI at 11–13 weeks were measured in 53 cases that developed PE, including 18 that required delivery before 34 weeks (early‐PE) and 106 unaffected controls. The measured IGF‐I concentration and uterine artery PI were converted into a multiple of the expected median (MoM) in unaffected pregnancies, and median MoM values were compared in the outcome groups. The significance of association of IGF‐I MoM with uterine artery PI MoM was determined by regression analysis. Results In the early‐PE and late‐PE groups, compared to the unaffected controls, the median IGF‐I decreased (0.53 and 0.55 MoM, respectively) and uterine artery PI increased (1.55 and 1.21 MoM, respectively). In the group that developed PE, there was no significant association between serum IGF‐I and uterine artery PI (p = 0.632). Conclusion In pregnancies destined to develop PE, the circulating levels of IGF‐I decrease from the first trimester of pregnancy suggesting that IGF‐I may be implicated in the pathogenesis of the disease. Copyright © 2010 John Wiley & Sons, Ltd.
Prenatal Diagnosis – Wiley
Published: Nov 1, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.